Is there a generic for Reserpine; trichlormethiazide?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Reserpine; trichlormethiazide, referencing the brand METATENSIN #2. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Reserpine; trichlormethiazide?

METATENSIN #2 (NDA 012972, SANOFI AVENTIS US) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Reserpine; trichlormethiazide are approved?

Reserpine; trichlormethiazide is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Reserpine; trichlormethiazide

Reserpine; trichlormethiazide is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:METATENSIN #2 · NDA 012972

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
METATENSIN #2×2	SANOFI AVENTIS US	NDA 012972	—	Approved Prior to Jan 1, 1982
NAQUIVAL	SCHERING	NDA 012265	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
TRICHLORMETHIAZIDE W/ RESERPINE	WATSON LABS	ANDA 085248	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Reserpine; trichlormethiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo